Searched for
LARGEST GENERICS DRUGMAKER
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...16 Jun, 2026, 06.27 PM IST- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...03 Jun, 2026, 11.31 PM IST
- Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...25 May, 2026, 10.31 AM IST
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...27 Apr, 2026, 11.27 PM IST
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...27 Apr, 2026, 10.33 AM IST
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...24 Apr, 2026, 08.17 AM IST
- Indian drugmakers flood market with cheaper versions of Novo's Ozempic, WegovyIndian drugmakers have launched affordable generic versions of popular diabetes and weight-loss drugs. This move significantly reduces trea...23 Mar, 2026, 12.54 PM IST
- Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and WegovyBiocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key markets like Canad...02 Jul, 2025, 08.15 AM IST
- Indian drugmakers likely to be hit as Trump plans pharmaceutical import tariffsU.S. President Donald Trump plans to impose 25% or higher tariffs on semiconductors and pharmaceutical imports, increasing over a year. Thi...19 Feb, 2025, 04.06 PM IST
- Viatris president Rajiv Malik to retire in April next yearMalik was instrumental in the $12 billion merger of Mylan with Pfizer's generic drug unit that resulted in the creation of Viatris in 2019....21 Oct, 2023, 10.47 PM IST
- Chennai startup Eywa enters US pharma marketEywa Pharma, based in Chennai and with offices in New Jersey, is the new pharma kid on the block that is entering the US market.25 Aug, 2019, 11.40 PM IST
- Strides Arcolab sells drug injectible business for Rs 9000 crore to MylanThe purchase values Agila at 18.7 times December 2012 operating profit of $86 million and seven times its sales of $255 million.01 Mar, 2013, 05.00 AM IST
- Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30Following a settlement in 2008, Pfizer Inc gave Ranbaxy exclusive marketing rights to sell Lipitor's low-cost version for six months.09 Sep, 2011, 05.18 AM IST
- Ranbaxy's Lipitor copy fate next weekA US court will decide next week if Ranbaxy can launch its low-priced version of the world's best selling drug Lipitor in the American mark...30 Apr, 2011, 01.57 AM IST
- Trouble ahead as US hints at tighter norms for genericsA top official with the US drugs regulator has hinted at tighter regulation for generic drugs, a move that could spell trouble for the Indi...23 Oct, 2010, 05.41 AM IST
- Lupin can't sell pill in US, Teva files patent suitIsraeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from sel...20 Jan, 2010, 03.45 AM IST
- Drug cos want to sell their low-cost advantageThe drug industry is pinning its hopes on Obama-led Democrat government to increase its sales in the US as the new administration plans to ...22 Jan, 2009, 01.25 AM IST
Load More
